XNAS:SCON Quarterly Report 10-Q Filing - 6/30/2012

Effective Date 6/30/2012

XNAS:SCON Fair Value Estimate
Premium
XNAS:SCON Consider Buying
Premium
XNAS:SCON Consider Selling
Premium
XNAS:SCON Fair Value Uncertainty
Premium
XNAS:SCON Economic Moat
Premium
XNAS:SCON Stewardship
Premium
 
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 0-21074

 

 

SUPERCONDUCTOR TECHNOLOGIES INC.

(Exact name of registrant as specified in our charter)

 

 

 

Delaware   77-0158076
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)

460 Ward Drive,

Santa Barbara, California 93111-2356

(Address of principal executive offices & zip code)

(805) 690-4500

(Registrant’s telephone number including area code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   ¨    Accelerated Filer   ¨
Non-Accelerated Filer   ¨  (do not check if smaller reporting company)    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨ or No  x

We had 40,243,048 shares of our common stock outstanding as of the close of business on August 7, 2012.

 

 

 


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

INDEX TO FORM 10-Q

Three and Six Months Ended June 30, 2012

 

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

     2   

PART I -

 

FINANCIAL INFORMATION

  
 

ITEM 1.

   

Financial Statements

  
 

Condensed Consolidated Statements of Operations

     3   
 

Condensed Consolidated Balance Sheets

     4   
 

Condensed Consolidated Statements of Cash Flows

     5   
 

Notes to Unaudited Interim Condensed Consolidated Financial Statements.

     6   
 

ITEM 2.

   

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     16   
 

ITEM 3.

   

Quantitative and Qualitative Disclosures About Market Risk

     22   
 

ITEM 4.

   

Controls and Procedures

     22   

PART II -

 

OTHER INFORMATION

  
 

ITEM 1.

   

Legal Proceedings

     22   
 

ITEM 1A.

   

Risk Factors

     22   
 

ITEM 2.

   

Unregistered Sales of Equity Securities and Use of Proceeds

     23   
 

ITEM 3.

   

Defaults Upon Senior Securities

     23   
 

ITEM 4.

   

Mine Safety Disclosures

     23   
 

ITEM 5.

   

Other Information

     23   
 

ITEM 6.

   

Exhibits

     23   

SIGNATURES

     24   

 

1


Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for these forward looking statements. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and the adequacy of our funding. Other statements contained in this Report that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and other comparable terminology.

We caution investors that any forward-looking statements presented in this Report, or that we may make orally or in writing from time to time, are based on our beliefs and assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

 

   

limited cash and a history of losses;

 

   

our need to raise additional capital for our business;

 

   

our need to overcome additional technical challenges necessary to develop and commercialize HTS wire;

 

   

limited number of potential customers;

 

   

decreases in average selling prices for our products;

 

   

rapidly advancing technology in our target markets;

 

   

the impact of competitive products, technologies and pricing;

 

   

limited number of suppliers for some of our components;

 

   

no significant backlog from quarter to quarter;

 

   

fluctuations in sales and product demand from quarter to quarter can be significant;

 

   

our proprietary rights, while important to our business, are difficult and costly to protect;

 

   

manufacturing capacity constraints and difficulties;

 

   

the current worldwide recession; and

 

   

cost and uncertainty from compliance with environmental regulations.

For further discussion of these and other factors see, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in our Annual Report on Form 10-K for 2011.

This Report and all subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after the date of this Report.

 

2


Table of Contents

PART I

FINANCIAL INFORMATION

 

Item 1. Financial Statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

     Three Months Ended     Six Months Ended  
     June 30, 2012     July 2, 2011     June 30, 2012     July 2, 2011  

Net revenues:

        

Net commercial product revenues

   $ 529,000      $ 1,101,000      $ 873,000      $ 2,704,000   

Government and other contract revenues

     67,000        15,000        122,000        32,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net revenues

     596,000        1,116,000        995,000        2,736,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses:

        

Cost of commercial product revenues

     1,078,000        1,265,000        1,922,000        2,934,000   

Cost of government and other contract revenue

     43,000        15,000        95,000        30,000   

Research and development

     1,314,000        1,361,000        2,475,000        3,349,000   

Selling, general and administrative

     1,604,000        1,679,000        2,952,000        3,335,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total costs and expenses

     4,039,000        4,320,000        7,444,000        9,648,000   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (3,443,000     (3,204,000     (6,449,000     (6,912,000

Other Income and Expense:

        

Other income

     21,000        —          37,000        —     

Interest income

     3,000        2,000        5,000        4,000   

Interest expense

     —          (7,000     —          (14,000
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (3,419,000   $ (3,209,000   $ (6,407,000   $ (6,922,000
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic and diluted loss per common share

   $ (0.09   $ (0.10   $ (0.17   $ (0.22
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares outstanding

     39,904,601        32,184,816        37,741,166        31,196,697   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the unaudited interim condensed consolidated financial statements.

 

3


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

     June 30,
2012
    December 31,
2011
 
     (Unaudited)     (See Note)  

ASSETS

    

Current Assets:

    

Cash and cash equivalents

   $ 5,370,000      $ 6,165,000   

Accounts receivable, net

     284,000        61,000   

Inventory, net

     1,152,000        1,609,000   

Prepaid expenses and other current assets

     560,000        472,000   
  

 

 

   

 

 

 

Total Current Assets

     7,366,000        8,307,000   
  

 

 

   

 

 

 

Property and equipment, net of accumulated depreciation of $19,301,000 and $19,748,000, respectively

     5,135,000        2,871,000   

Patents, licenses and purchased technology, net of accumulated amortization of $2,390,000 and $2,342,000, respectively

     1,380,000        1,409,000   

Other assets

     357,000        362,000   
  

 

 

   

 

 

 

Total Assets

   $ 14,238,000      $ 12,949,000   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current Liabilities:

    

Accounts payable

   $ 1,185,000      $ 534,000   

Accrued expenses

     561,000        612,000   
  

 

 

   

 

 

 

Total Current Liabilities

     1,746,000        1,146,000   

Other long term liabilities

     628,000        628,000   
  

 

 

   

 

 

 

Total Liabilities

     2,374,000        1,774,000   
  

 

 

   

 

 

 

Commitments and contingencies-Notes 6 and 7

    

Stockholders’ Equity:

    

Preferred stock, $.001 par value, 2,000,000 shares authorized, 564,642 shares issued and outstanding

     1,000        1,000   

Common stock, $.001 par value, 250,000,000 shares authorized, 40,335,085 and 33,362,281 shares issued and outstanding, respectively

     40,000        33,000   

Capital in excess of par value

     269,246,000        262,157,000   

Accumulated deficit

     (257,423,000     (251,016,000
  

 

 

   

 

 

 

Total Stockholders’ Equity

     11,864,000        11,175,000   
  

 

 

   

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 14,238,000      $ 12,949,000   
  

 

 

   

 

 

 

See accompanying notes to the unaudited interim condensed consolidated financial statements.

Note – December 31, 2011 balances were derived from audited consolidated financial statements.

 

4


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

     Six Months Ended  
     June 30, 2012     July 2, 2011  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net loss

   $ (6,407,000   $ (6,922,000

Adjustments to reconcile net loss to net cash used for operating activities:

    

Depreciation and amortization

     130,000        410,000   

Stock-based compensation expense

     559,000        818,000   

Write-off of intangibles

     87,000        770,000   

Provision for excess and obsolete inventories

     182,000        —     

Gain on disposal of property and equipment

     (37,000     —     

Changes in assets and liabilities:

    

Accounts receivable

     (222,000     (1,000

Inventories

     276,000        (73,000

Prepaid expenses and other current assets

     (89,000     44,000   

Patents and licenses

     (115,000     (46,000

Other assets

     5,000        3,000   

Accounts payable, accrued expenses and other current liabilities

     175,000        191,000   
  

 

 

   

 

 

 

Net cash used in operating activities

     (5,456,000     (4,806,000
  

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Purchases of property and equipment

     (1,863,000     (647,000

Net proceeds from sale of property and equipment

     37,000        —     
  

 

 

   

 

 

 

Net cash used in investing activities

     (1,826,000     (647,000
  

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Repurchase of common shares for withholding obligations

     (134,000     (303,000

Net proceeds from the sale of common stock

     6,621,000        12,402,000   
  

 

 

   

 

 

 

Net cash provided by financing activities

     6,487,000        12,099,000   
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     (795,000     6,646,000   

Cash and cash equivalents at beginning of period

     6,165,000        6,069,000   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 5,370,000      $ 12,715,000   
  

 

 

   

 

 

 

See accompanying notes to the unaudited interim condensed consolidated financial statements.

 

5


Table of Contents

SUPERCONDUCTOR TECHNOLOGIES INC.

NOTES TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. General

We are a leading company in developing and commercializing high temperature superconductor (“HTS”) materials and related technologies. Superconductivity is the unique ability to conduct various signals or energy (e.g., electrical current or radio frequency (“RF”) signals) with little or no resistance when cooled to “critical” temperatures. HTS materials are a family of elements that demonstrate superconducting properties at temperatures significantly warmer than previous superconducting materials. Electric currents that flow through conventional conductors encounter resistance which causes power loss and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reducing power loss, lowering heat generation, and decreasing electrical noise.

We were established in 1987 shortly after the discovery of HTS materials, a family of elements that demonstrate superconducting properties at temperatures significantly warmer than previous superconducting materials. Our stated objective was to develop products based on these materials for the commercial marketplace.

After analyzing the market opportunities available, we decided to pursue a strategic revenue opportunity developing products for the electronics industry.

Our initial product was completed in 1998, and we began delivery to a number of wireless network providers. In the following 14 years, we continued to refine and improve the platform, with the primary focus on improving reliability, increasing performance and runtime, and, most importantly, removing cost from the manufacturing process of the required subsystems. Our cost reducing efforts led to the invention of our proprietary, high-yield and high throughput HTS material deposition manufacturing process.

In the last several years, we have focused our research and development efforts on adapting our successful HTS materials deposition techniques to the production of high performance second generation “2G” HTS wire for next generation power applications. While all our current commercial product revenues come from the sale of high performance wireless infrastructure products, we now see production of our Conductus® HTS wire as an excellent strategic opportunity to grow our future revenue.

For the six months ended June 30, 2012 and July 2, 2011, commercial product revenues accounted for 88% and 99% of our net revenues, respectively.

Our research and development contracts are used as a source of funds for our commercial technology development. We continue to be involved as either contractor or subcontractor on a number of contracts with the U.S. government. For the six months ended June 30, 2012 and July 2, 2011, government and other contract revenues accounted for 12% and 1%, respectively, of our net revenues.

The unaudited condensed consolidated financial information furnished herein has been prepared in accordance with generally accepted accounting principles and reflects all adjustments, consisting only of normal recurring adjustments, which, in the opinion of management, are necessary for a fair statement of the results of operations for the periods presented.

The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements. This quarterly report on Form 10-Q should be read in conjunction with our Form 10-K for 2011. The results of operations for the six months ended June 30, 2012 are not necessarily indicative of the results for all of 2012.

2. Summary of Significant Accounting Policies

Basis of Presentation

For the six months ended June 30, 2012, we incurred a net loss of $6.4 million and negative cash flows from operations of $5.5 million. For the full year 2011, we incurred a net loss of $13.4 million and had negative cash flows from operations of $10.0 million.

At June 30, 2012, we had $5.4 million in cash and cash equivalents. Our current cash resources will not be sufficient to fund our planned operations for the next twelve months. We believe the key factors to our liquidity will be our

 

6


Table of Contents

ability to successfully use our expertise and our technology to generate revenues in various ways, including commercial operations, government contracts, joint ventures and licenses. Because of the uncertainty of these factors, we will need to raise funds to meet our working capital needs. Additional financing may not be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and, ultimately, our viability as a company.

Our condensed consolidated financial statements do not include any adjustments that might result from this uncertainty and have been prepared assuming that we will continue as a going concern.

Principles of Consolidation

The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the condensed consolidated financial statements.

Cash and Cash Equivalents

Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with what we believe to be quality financial institutions and from time to time exceed FDIC limits. Historically, we have not experienced any losses due to such concentration of credit risk.

Accounts Receivable

We sell predominantly to entities in the wireless communications industry and to entities of the U.S. government. We grant uncollateralized credit to our customers. We perform usual and customary credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience. Past due balances are reviewed for collectibility. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers.

Revenue Recognition

Commercial revenues are principally derived from the sale of our SuperLink, AmpLink and SuperPlex family of products and are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) customer’s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.

Contract revenues are principally generated under research and development contracts. Contract revenues are recognized utilizing the percentage-of-completion method measured by the relationship of costs incurred to total estimated contract costs. If the current contract estimate were to indicate a loss, utilizing the funded amount of the contract, a provision would be made for the total anticipated loss. Revenues from research related activities are derived primarily from contracts with agencies of the U.S. Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. These contracts include cost-plus, fixed price and cost sharing arrangements and are generally short-term in nature.

All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Contract audits through 2003 are closed. Based on historical experience and review of current projects in process, we believe that the audits will not have a significant effect on our financial position, results of operations or cash flows.

Shipping and Handling Fees and Costs

Shipping and handling fees billed to customers are included in net commercial product revenues. Shipping and handling fees associated with freight are generally included in cost of commercial product revenues.

Warranties

We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties require us to repair or replace defective product returned to us during such warranty period at no cost to the customer. An estimate by us for warranty related costs is recorded by us at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations.

 

7


Table of Contents

Indemnities

In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnities because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these indemnities.

Research and Development Costs

Research and development costs are charged to expense as incurred and include salary, facility, depreciation and material expenses. Research and development costs incurred solely in connection with research and development contracts are charged to government and other contract expense. Additionally, in 2011, we decided to use certain of our own technologies and we therefore voluntarily terminated a patent license we had with a third party along with certain other related intangible assets. As a result, a capitalized cost of $0.8 million was charged to research and development during the first quarter of 2011. There were no such charges in the three and six months ended June 30, 2012.

Inventories

Inventories are stated at the lower of cost or market, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our inventory reserves establish a new cost basis for inventory and are not reversed until we sell or dispose of the related inventory. Such provisions are established based on historical usage, adjusted for known changes in demands for such products, or the estimated forecast of product demand and production requirements. Costs associated with idle capacity are charged to expense immediately.

Property and Equipment

Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to seven years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administrative expenses. In the three and six months ended June 30, 2012, there were disposals totaling $180,000 and $520,000, respectively, and gains of $22,000 and $37,000, respectively, from these disposals. In the three and six months ended July 2, 2011, there were disposals totaling zero and $152,000, respectively.

Patents, Licenses and Purchased Technology

Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or approximately seventeen years. Purchased technology acquired through the acquisition of Conductus, Inc. in 2002 was recorded at our estimated fair value and was amortized using the straight-line method over seven years ended in 2009.

Long-Lived Assets

The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in business are written off in the period identified since they will no longer generate any positive cash flows for us. Long-lived assets that will continue to be used by us are periodically evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets is written down to its estimated fair value. We tested our long lived assets for recoverability during 2011 and did not believe that there was any impairment.

While we believe the expected cash flows from these long-lived assets, including intangible assets, exceed the carrying amounts, materially different assumptions regarding future performance and discount rates could result in future impairment

 

8


Table of Contents

losses. In particular, if we no longer believe we will achieve our long-term projected sales or operating expenses, we may conclude, in connection with any future impairment tests, that the estimated fair value of our long-lived assets, including intangible assets, is less than the book value and recognize an impairment charge. Any impairment charge would adversely affect our earnings.

Other Investments

From time to time we may pursue joint ventures with other entities to commercialize our technology. In 2007, we formed a joint venture with Hunchun BaoLi Communication Co. Ltd. to manufacture and sell our SuperLink interference elimination solution in China. We use the equity method of accounting for our 45 percent joint venture interest. The joint venture agreement called for our joint venture partner to supply the capital and local expertise, and for us to provide a license of certain technology and supply key parts for manufacturing. Since 2007, we have been conducting lab and field trials in the existing China 2G market using our TD-SCDMA and SuperLink solutions. Although those activities continue, the parties have not completed their contributions to the joint venture, including most of the funding and our license, within the two year period specified by the agreement and Chinese law. The future of the joint venture, including any commencement of manufacturing and the transfer of our processes, will depend on product demand in China, completion of funding by our joint venture partner, as well as a number of other conditions, including certain critical approvals from the Chinese and U.S. governments. There continues to be no assurance that these conditions will be met and even if these conditions are met and the approvals received, the results from our joint venture will be subject to a number of significant risks associated with international operations and new ventures, some of which are set forth in our public filings, including in particular the “Risk Factors” included in Item 1A of our Annual Report on Form 10-K for 2011. We incurred no expenses in the six months ended June 30, 2012 or in the full year 2011 as a result of this joint venture.

In July 2012 we announced we were contributing 14 patents regarding our innovative Reconfigurable Resonance™ (RcR) technology, experienced executive leadership and technical expertise as our minority investment in Resonant LLC. Resonant intends to commercialize RcR for the mobile communication products industry. The contributed patents do not relate to either our current wireless business nor to our 2G HTS wire initiative.

Loss Contingencies

In the normal course of our business we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. The costs of our defense in such matters are expensed as incurred. Insurance proceeds recoverable are recorded when deemed probable.

Income Taxes

We recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The guidance further clarifies the accounting for uncertainty in income taxes and sets a consistent framework to determine the appropriate level of tax reserve to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized and sets out disclosure requirements to enhance transparency of our tax reserves. The adoption of this guidance has not had a material impact on our consolidated financial statements as we concluded our tax positions are highly certain of being settled at 100% of the benefit claimed. Guidance is also provided on the accounting for the related interest and penalties, financial statement and disclosure. We are currently not under examination by any taxing authority nor have we been notified of an impending examination. The oldest tax year that remains open to possible evaluation and interpretation of our tax position is 1996.

As of December 31, 2011, we had net operating loss carryforwards for federal and state income tax purposes of approximately $308.4 million and $181.5 million, respectively, which expire in the years 2012 through 2031. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.

Marketing Costs

All costs related to marketing and advertising our products are charged to expense as incurred or at the time the advertising takes place. Advertising costs were not material in each of the three and six months ended June 30, 2012 and July 2, 2011.

 

9


Table of Contents

Net Loss Per Share

Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each year. Outstanding stock options and unvested restricted stock awards are not included in the calculation of diluted loss per share because their effect is anti-dilutive.

Stock-based Compensation

We grant both restricted stock awards and stock options to our key employees, directors and consultants. For the three and six months ended June 30, 2012 and July 2, 2011, the weighted average fair value of options was estimated at the date of the grant using the Black-Scholes option-pricing model. The following are the significant weighted average assumptions used for estimating the fair value under our stock option plans:

 

     Three months ended      Six months ended  
     June 30, 2012     July 2, 2011      June 30, 2012     July 2, 2011  

Expected life in years

     4.0        —           4.0        4.0   

Risk free interest rate

     0.5     —           0.6     1.52

Expected volatility

     99     —           100     111

Dividend yield

     0     —           0     0

The expected life was based on the contractual term of the options and expected employee exercise behavior. Typically, options to our employees have a 2 to 4 year vesting term and a 10 year contractual term. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected option life assumed at the grant date. The future volatility is based on our 4 year historical volatility. We used an expected dividend yield of 0% because we have never paid a dividend and do not anticipate paying dividends. We assumed a 10% forfeiture rate based on our historical stock option cancellation rates over the last 4 years.

The stock-based compensation expense for our restricted stock awards is measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of our common stock. We also assumed a 10% forfeiture rate for our restricted stock awards based on our historical cancellation rates over the last 4 years.

The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:

 

     Three months ended      Six months ended  
     June 30, 2012      July 2, 2011      June 30, 2012      July 2, 2011  

Cost of revenue

   $ 3,000       $ 4,000       $ 8,000       $ 8,000   

Research and development

     77,000         130,000         178,000         244,000   

Selling, general and administrative

     158,000         289,000         373,000         566,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 238,000       $ 423,000       $ 559,000       $ 818,000   
  

 

 

    

 

 

    

 

 

    

 

 

 

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the condensed consolidated financial statements relate to the assessment of the carrying amount of accounts receivable, inventory, fixed assets, intangibles, estimated provisions for warranty costs, contract revenues, income taxes and disclosures related to litigation. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Fair Value of Financial Instruments

We have estimated the fair value amounts of our financial instruments using the available market information and valuation methodologies considered appropriate. We determined the book value of our cash and cash equivalents, accounts receivable, inventory, prepaid expenses and other current assets, and other current liabilities as of June 30, 2012 approximate fair value.

Comprehensive Income

We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.

 

10


Table of Contents

Segment Information

We operate in a single business segment, the research, development, manufacture and marketing of high performance products used in cellular base stations to maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. We currently derive net commercial product revenues primarily from the sales of our SuperLink, AmpLink and SuperPlex products. We currently sell most of our products directly to wireless network operators in the United States. Net revenues derived principally from government research and development contracts are presented separately on the condensed consolidated statement of operations for all periods presented.

Certain Risks and Uncertainties

Our long-term prospects are dependent upon the continued and increased market acceptance for the products.

We currently sell most of our products directly to wireless network operators in the United States and our product sales have historically been concentrated in a small number of customers. At June 30, 2012, we had two customers that represented 40% and 39% of total net revenues and 76% of accounts receivable. In 2011, these two customers represented 79% and 14% of total net revenues and 34% of accounts receivable. The loss of or reduction in sales, or the inability to collect outstanding accounts receivable, from any of these customers could have a material adverse effect on our business, financial condition, results of operations and cash flows.

We currently rely on a limited number of suppliers for key components of our products. The loss of any of these suppliers could have material adverse effect on our business, financial condition, results of operations and cash flows.

In connection with the sales of our commercial products, we indemnify, without limit or term, our customers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnity obligations because of the uncertainty as to whether a claim might arise and how much it might total.

Consulting Agreements with Former Directors

On May 4, 2012, director John Lockton resigned from our Board of Directors, and on May 5, 2012 we entered into an exclusive consulting agreement with Mr. Lockton whereby he will provide our Board of Directors consulting services for a term commencing upon his resignation and ending March 31, 2013.

On May 6, 2012, we also entered into an exclusive consulting agreement with director Dennis Horowitz, who retired as a director upon conclusion of his term as a director at our May 22, 2012 annual stockholders’ meeting, whereby Mr. Horowitz will provide the our Board of Directors consulting services for a term commencing on May 22, 2012 and ending March 31, 2013.

Each of Mr. Lockton’s and Mr. Horowitz’s consulting agreements provides for total compensation of $35,000 and 10,000 shares of restricted common stock subject to vesting during the term. Consistent with past practice, effective as of their respective dates of termination of board service, we also extended the exercise period of options held by such director to the term of the options and accelerated the vesting of previously granted restricted stock.

3. Stockholders’ Equity

The following is a summary of stockholders’ equity transactions for the six months ended June 30, 2012:

 

     Convertible                  

Capital in

Excess of

   

Accumulated

    Total  
     Preferred Stock      Common Stock         
     Shares      Amount      Shares     Amount      Par Value     Deficit    

Balance at December 31, 2011

     564,642       $ 1,000         33,362,281      $ 33,000       $ 262,157,000      $ (251,016,000   $ 11,175,000   

Issuance of common stock, net

           6,808,591        7,000         6,614,000          6,621,000   

Repurchase of common stock to satisfy tax withholding obligations

           (97,229        (134,000       (134,000

Issuance of awards and stock based compensation

           261,442           609,000          609,000   

Net loss

                  (6,407,000     (6,407,000
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Balance at June 30, 2012

     564,642       $ 1,000         40,335,085      $ 40,000       $ 269,246,000      $ (257,423,000   $ 11,864,000   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

11


Table of Contents

Equity Offering

In a registered direct offering completed in February 2012 we raised proceeds of $6.5 million, net of offering costs of $577,000, from the sale of 6,711,219 shares of common stock and warrants to purchase up to 5,033,414 shares of common stock. The securities were sold in multiples of a fixed combination consisting of one share of common stock and a warrant to purchase up to 0.75 of a share of common stock, at a price of $1.05, for an aggregate offering price of $7.1 million. Each warrant has an exercise price of $1.35 per share, for total potential additional proceeds to us of up to $6.8 million upon exercise of the warrants. The warrants are exercisable at any time but not prior to the six-month anniversary of the issuance of the warrants and have a five-year term. The warrants are exercisable by paying cash or, solely in the absence of an effective registration statement or prospectus, by cashless exercise for unregistered shares of common stock. The exercise price of the warrants is subject to standard antidilutive provision adjustment in the case of stock dividends or other distributions on shares of common stock or any other equity or equity equivalent securities payable in shares of common stock, stock splits, stock combinations, reclassifications or similar events affecting our common stock, and also, subject to limitations, upon any distribution of assets, including cash, stock or other property to our stockholders. The exercise price of the warrants is not subject to “price-based” anti-dilution adjustment.

Prior to the February direct offering and commensurate with a previously announced plan, on various dates in January and February 2012, we raised $151,000, net of commission costs of $5,000, from at-the-market sales to or through Citadel Securities of 97,372 shares of our common stock at an average price of $1.60 per share.

Stock Options

At June 30, 2012, we had two equity award option plans, the 1999 Stock Option Plan and the 2003 Equity Incentive Plan (collectively, the “Stock Option Plans”) although we can only grant new options under the 2003 Equity Incentive Plan. Under the 2003 Equity Incentive Plan, stock awards may be made to our directors, key employees, consultants, and non-employee directors and may consist of stock options, stock appreciation rights, restricted stock awards, performance awards, and performance share awards. Stock options must be granted at prices no less than the market value on the date of grant. There were no stock option exercises during the three or six months ended June 30, 2012 or during the three or six months ended July 2, 2011.

The impact to the condensed consolidated statements of operations was $88,000 and $242,000 and less than $0.01 and $0.01 on basic and diluted earnings per share for the three and six months ended June 30, 2012, respectively, compared to $191,000 and $362,000 and $0.01 and $0.01 on basic and diluted earnings per share for the three and six months ended July 2, 2011, respectively. No stock compensation cost was capitalized during either period. The total compensation cost related to nonvested awards not yet recognized was $848,000 and the weighted-average period over which the cost is expected to be recognized was 1.5 years at June 30, 2012.

The following is a summary of stock option transactions under our stock option plans at June 30, 2012:

 

     Number of
Shares
    Price Per Share    Weighted
Average
Exercise
Price
     Number of
Options
Exercisable
     Weighted
Average
Exercise
Price
 

Balance at December 31, 2011

     1,376,513      $1.43 - $74.50    $ 4.44         735,701       $ 6.64   

Granted

     217,500      .68 - 1.46      1.36         

Exercised

     —                
             

Canceled

     (114,351   1.46 - 69.00      9.23         
  

 

 

   

 

  

 

 

    

 

 

    

 

 

 

Balance at June 30, 2012

     1,479,662      $.68 - $74.50    $ 3.62         978,607       $ 4.59   
  

 

 

   

 

  

 

 

    

 

 

    

 

 

 

The outstanding options expire on various dates through June 2022. The weighted-average contractual term of options outstanding is 6.5 years and the weighted-average contractual term of stock options currently exercisable is 5.3 years. The exercise prices for these options range from $0.68 to $74.50 per share, for an aggregate exercise price of approximately $5.4 million. At June 30, 2012, no outstanding options had an exercise price less than the current market value.

 

12


Table of Contents

Restricted Stock Awards

The grant date fair value of each share of our restricted stock awards is equal to the fair value of our common stock at the grant date. Shares of restricted stock under awards all have service conditions and vest over one to four years. Some of our grants also have performance conditions. The following is a summary of our restricted stock award transactions at June 30, 2012:

 

     Number of
Shares
    Weighted
Average Grant
Date Fair Value
 

Balance nonvested at December 31, 2011

     641,813      $ 1.92   

Granted

     308,019        1.16   

Vested

     (334,416     1.93   

Forfeited

     (46,575     1.68   
  

 

 

   

 

 

 

Balance nonvested at June 30, 2012

     568,841      $ 1.52   
  

 

 

   

 

 

 

For the majority of restricted stock awards granted, the number of shares issued on the date the restricted stock awards vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. During the three and six months ended June 30, 2012, we withheld 7,233 and 97,229 shares, respectively, to satisfy $5,000 and $134,000 of employees’ tax obligations. During the three months ended July 2, 2011, we withheld 8,983 and 179,636 shares, respectively, to satisfy $25,000 and $303,000 of employees’ tax obligations.

The impact to the condensed consolidated statements of operations was $149,000 and $317,000 and less than $0.01 and $0.01 on basic and diluted earnings per share for the three and six months ended June 30, 2012, respectively, and $231,000 and $456,000 and $0.01 and $0.01 on basic and diluted earnings per share for the three and six months ended July 2, 2011, respectively. No stock compensation cost was capitalized during the period. The total compensation cost related to nonvested awards not yet recognized was $524,000, and the weighted-average period over which the cost is expected to be recognized was 9 months.

Warrants

The following is a summary of outstanding warrants at June 30, 2012:

 

     Common Shares
     Total      Currently
Exercisable
     Price per
Share
     Expiration Date

Warrants related to February 2012 financing

     5,033,414         0       $ 1.35       February 22, 2017*

 

* The warrants are exercisable at any time but not prior to the six-month anniversary of the issuance of the warrants and have a five-year term. The warrants are exercisable by paying cash or, solely in the absence of an effective registration statement or prospectus, by cashless exercise for unregistered shares of common stock. The exercise price of the warrants is subject to standard antidilutive provision adjustment in the case of stock dividends or other distributions on shares of common stock or any other equity or equity equivalent securities payable in shares of common stock, stock splits, stock combinations, reclassifications or similar events affecting our common stock, and also, subject to limitations, upon any distribution of assets, including cash, stock or other property to our stockholders. The exercise price of the warrants is not subject to “price-based” anti-dilution adjustment.

We have determined that these 5,033,414 warrants related to issuance of common stock are subject to equity treatment because the warrant holder has no right to demand cash settlement and there are no unusual anti-dilution rights.

4. Earnings Per Share

Basic and diluted earnings (loss) per share is based on the weighted-average number of common shares outstanding.

Since their impact would be anti-dilutive, our loss per common share does not include the effect of the assumed exercise or vesting of the following shares:

 

     June 30, 2012      July 2, 2011  

Outstanding stock options

     1,479,662         1,653,627   

Unvested restricted stock awards

     568,841         805,406   

Outstanding warrants

     5,033,414         —     
  

 

 

    

 

 

 

Total

     7,081,917         2,459,033   
  

 

 

    

 

 

 

Also, the preferred stock convertible into 5,646,420 shares of common stock was not included since its impact would be anti-dilutive.

 

13


Table of Contents

5. Commitments and Contingencies

Operating Leases

We lease our offices and production facilities under non-cancelable operating leases that expire in November 2016 and April 2017. The leases contain escalation clauses for increases in annual renewal options and require us to pay utilities, insurance, taxes and other operating expenses. Commencing January 1, 2012 and expiring in November 2016 we sublet 26,000 square feet of our Santa Barbara facility and entered into a lease for a 35,000 square foot facility in Austin, Texas that expires in April 2017.

For the three and six months ended June 30, 2012 rent expense was $200,000 and $509,000, respectively, and for the three and six months ended July 2, 2011 rent expense was $274,000 and $551,000, respectively.

Patents and Licenses

We have entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that we fail to pay minimum annual royalties, these licenses may automatically become non-exclusive or be terminated. These royalty obligations terminate at various times from 2012 to 2020. Royalty expense totaled $4,000 and $10,000 in the second quarter and year to date in 2012, respectively, compared to $44,000 and $87,000 in the second quarter and year to date in 2011, respectively. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and we do not expect future audit adjustments to be significant.

The minimum lease payments under operating leases and license obligations are as follows:

 

Years ending December 31,

   Licenses      Operating Leases  

Remainder of 2012

   $ —         $ 778,000   

2013

     25,000         1,595,000   

2014

     30,000         1,644,000   

2015

     45,000         1,694,000   

2016

     45,000         1,621,000   

Thereafter

     90,000         67,000   
  

 

 

    

 

 

 

Total payments

   $ 235,000       $ 7,399,000   
  

 

 

    

 

 

 

6. Contractual Guarantees and Indemnities

During our normal course of business, we make certain contractual guarantees and indemnities pursuant to which we may be required to make future payments under specific circumstances. We have not recorded any liability for these contractual guarantees and indemnities in the accompanying condensed consolidated financial statements.

Warranties

We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.

Intellectual Property Indemnities

We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

We have entered into indemnification agreements with our directors and executive officers which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnities may be

 

14


Table of Contents

recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such director and officer indemnities have not had a material negative effect on our business, financial condition or results of operations.

We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.

General Contractual Indemnities/Products Liability

During the normal course of business, we enter into contracts with customers where we agree to indemnify the other party for personal injury or property damage caused by our products. Our indemnification obligations under such agreements are not generally limited in amount or duration. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such indemnities have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance as well as errors and omissions insurance which may provide a source of recovery to us in the event of an indemnification claim.

7. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

Balance Sheet Data:

 

                                           
     June 30, 2012     December 31, 2011  

Accounts receivable:

    

Accounts receivable-trade

   $ 218,000      $ 15,000   

U.S. government accounts receivable-billed

     68,000        48,000   

Less: allowance for doubtful accounts

     (2,000     (2,000
  

 

 

   

 

 

 
   $        284,000      $        61,000   
  

 

 

   

 

 

 

 

                                           
     June 30, 2012     December 31, 2011  

Inventories:

    

Raw materials

   $ 1,077,000      $ 1,169,000   

Work-in-process

     321,000        338,000   

Finished goods

     1,674,000        1,887,000   

Less inventory reserve

       (1,920,000       (1,785,000
  

 

 

   

 

 

 
   $ 1,152,000      $ 1,609,000   
  

 

 

   

 

 

 

 

                                           
     June 30, 2012     December 31, 2011  

Property and Equipment:

    

Equipment

   $ 16,705,000      $ 15,557,000   

Leasehold improvements

     7,344,000        6,675,000   

Furniture and fixtures

     387,000        387,000   
  

 

 

   

 

 

 
     24,436,000        22,619,000   

Less: accumulated depreciation and amortization

     (19,301,000     (19,748,000
  

 

 

   

 

 

 
   $ 5,135,000      $ 2,871,000   
  

 

 

   

 

 

 

Depreciation expense amounted to $39,000 and $73,000, respectively, for the three and six month periods ended June 30, 2012 and $181,000 and $363,000, respectively, for the three and six month periods ended July 2, 2011.

 

     June 30, 2012     December 31, 2011  

Patents and Licenses:

    
  

 

 

   

 

 

 

Patents pending

   $ 596,000      $ 522,000   
  

 

 

   

 

 

 

Patents issued

     1,468,000        1,523,000   

Less accumulated amortization

     (684,000     (636,000
  

 

 

   

 

 

 

Net patents issued

     784,000        887,000   
  

 

 

   

 

 

 

Purchased technology

     1,706,000        1,706,000   

Less accumulated amortization

     (1,706,000     (1,706,000
  

 

 

   

 

 

 

Net purchased technology

     —          —     
  

 

 

   

 

 

 
    
  

 

 

   

 

 

 
   $ 1,380,000      $ 1,409,000   
  

 

 

   

 

 

 

 

15


Table of Contents

Amortization expense related to these items totaled $28,000 and $57,000, respectively, for the three and six month periods ended June 30, 2012 and $18,000 and $47,000, respectively, for the three and six month periods ended July 2, 2011. Amortization expenses are expected to total $74,000 for the remainder of 2012 and $89,000 in each of 2013 and 2014.

 

     June 30, 2012     December 31, 2011  

Accrued Expenses and Other Long Term Liabilities:

    

Salaries Payable

   $ 78,000      $ 68,000   

Compensated Absences

     255,000        272,000   

Compensation related

     72,000        20,000   

Warranty reserve

     195,000        225,000   

Deferred rent

     468,000        422,000   

Other

     121,000        233,000   
  

 

 

   

 

 

 
     1,189,000        1,240,000   

Less current portion

     (561,000     (612,000
  

 

 

   

 

 

 

Long term portion

   $ 628,000      $ 628,000   
  

 

 

   

 

 

 

 

     For the six months ended,  
     June 30, 2012     July 2, 2011  

Warranty Reserve Activity:

    

Beginning balance

   $ 225,000      $ 289,000   

Additions

     19,000        2,000   

Deductions

     (50,000     (4,000
  

 

 

   

 

 

 

Ending balance

   $ 194,000      $ 287,000   
  

 

 

   

 

 

 

8. Subsequent Events

In July 2012, we announced we were contributing 14 patents regarding our innovative Reconfigurable Resonance™ (RcR) technology, experienced executive leadership and technical expertise as our minority investment in Resonant LLC. Resonant intends to commercialize RcR for the mobile communication products industry. The contributed patents do not relate to either our current wireless business nor to our 2G HTS wire initiative.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

We are a leading company in developing and commercializing high temperature superconductor (“HTS”) materials and related technologies. Superconductivity is the unique ability to conduct various signals or energy (e.g., electrical current or radio frequency (“RF”) signals) with little or no resistance when cooled to “critical” temperatures. HTS materials are a family of elements that demonstrate superconducting properties at temperatures significantly warmer than previous superconducting materials. Electric currents that flow through conventional conductors encounter resistance that requires power to overcome and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reducing power loss, lowering heat generation, and decreasing electrical noise.

Commercialization

Our development efforts over the last 25 years have yielded an extensive patent portfolio as well as critical trade secrets, unpatented technology and proprietary knowledge. We have commercialized wireless products using our proprietary technology and are currently focusing our efforts on commercializing this technology in superconducting power applications, RF filters and cryocoolers.

 

16


Table of Contents
   

Wireless Networks. Our current commercial products help maximize the performance of wireless telecommunications networks by improving the quality of uplink signals from mobile wireless devices. Our products increase capacity utilization, lower dropped and blocked calls, extend coverage, and enable higher wireless data throughput – all while reducing capital and operating costs for the carrier.

 

   

Superconducting Power Applications. We are adapting our unique HTS materials deposition techniques to deliver energy efficient, cost-effective and high performance 2G HTS wire technology for next generation power applications. We have identified several large initial target markets for our 2G HTS wire including energy (wind turbines, smart grid) and industrial (motors, generators) applications. To accelerate development and manufacturing processes for our 2G HTS wire, we are partnering with HTS industry leaders and the United States National Labs. In July 2011, we renewed our three year Cooperative Research and Development Agreement with Los Alamos National Laboratory. These technological interchanges will help us meet the technical challenges and performance metrics for both high performance and cost effective 2G HTS wire.

 

   

RF Filters. Our RF filter structures resemble a circuit on a semiconductor using a circuit that is etched into HTS materials that are deposited on a wafer. Our unique and innovative circuits allow us to utilize the characteristics of the HTS materials for this application, and we have developed unique tuning methods that allow us to produce a frequency specific filter. We are also leveraging our unique technology to design advanced reconfigurable filters, which have the potential to drastically reduce the size and cost of mobile devices.

 

   

Cryocoolers. We developed a unique cryocooler that can efficiently and reliably cool HTS circuits to the critical temperature (77 degrees Kelvin), and as a result, our wireless products are maintenance free and reliable enough to be deployed for many years.

Our development efforts can take a significant number of years to commercialize, and we must overcome significant technical barriers and deal with other significant risks.

Our Wireless Business

Our current revenue comes from the design, manufacture, and sale of high performance infrastructure products for wireless communication applications. We have three current product lines all of which relate to wireless base stations:

 

   

SuperLink®, a highly compact and reliable receiver front-end HTS wireless filter system to eliminate out-of-band interference for wireless base stations, combining filters with a proprietary cryogenic cooler and a cooled low-noise amplifier;

 

   

AmpLink®, a ground-mounted unit for wireless base stations that includes a high-performance amplifier and up to six dual duplexers; and

 

   

SuperPlex, a high-performance multiplexer that provides extremely low insertion loss and excellent cross-band isolation designed to eliminate the need for additional base station antennas and reduce infrastructure costs.

We sell most of our current commercial products to a small number of wireless carriers in the United States, including AT&T and Verizon Wireless. Verizon Wireless and AT&T each accounted for more than 10% of our commercial revenues in each of the last three years. Demand for wireless communications equipment fluctuates dramatically and unpredictably and recently has been trending downward. The wireless communications infrastructure equipment market is extremely competitive and is characterized by rapid technological change, new product development, product obsolescence, evolving industry standards and price erosion over the life of a product. We expect these trends to continue and they may cause significant fluctuations in our quarterly and annual revenues.

Our Strategic Initiatives

In addition to our ongoing sale of products for wireless applications described above, we have created several unique capabilities and an HTS manufacturing system related to a new HTS wire platform, RF filters and cryocoolers that we are seeking to commercially deploy by leveraging our leadership in superconducting technologies, extensive intellectual property, and HTS manufacturing expertise.

HTS Wire Platform

Our 2G HTS wire product development is focused on large markets where the advantages of HTS wire are recognized by the industry. Our initial product roadmap targets three important applications: superconducting high power transmission cable, superconducting fault current limiters (SFCL) and superconducting rotating machines such as motors and generators.

 

17


Table of Contents

Superconducting High Power Transmission Cable:

Superconducting high power transmission and distribution cable transmit 5 to 10 times the electrical current of traditional copper or aluminum cables with significantly improved efficiency. HTS power cable systems consist of the cable, which is comprised of hundreds of strands of HTS wire wrapped around a copper core, and the cryogenic cooling system to maintain proper operating conditions. HTS superconducting cables offer solutions for utilities facing challenges that include: substation footprint availability, lack of available rights of way, and high load connections between substations. HTS power cables are particularly suited to high load areas such as the dense urban business districts of large cities, where purchases of easements and construction costs for traditional low capacity cables may be cost prohibitive.

Superconducting Fault Current Limiter (SFCL):

With power demand on the rise and new power generation sources being added, the grid has become overcrowded and vulnerable to catastrophic faults. Faults are abnormal flows of electrical current like a short circuit. As the grid is stressed, faults and power blackouts increase in frequency and severity. SFCLs act like powerful surge protectors, preventing harmful faults from taking down substation equipment by reducing the fault current to a safer level (20 – 50% reduction) so that the existing switchgear can still protect the grid. SFCLs protect against damaging fault currents and blackouts while enhancing system safety, stability, and efficiency. A critical benefit for new build outs is the improved system reliability when renewables, like solar and wind, are added. When compared to a complete substation upgrade, SFCLs are a significantly lower capital investment.

Superconducting Rotating Machines – Motors and Generators:

Superconducting motors, generators, turbines and other rotating machines are expected to generate large future demand for 2G HTS wire. Coils utilizing HTS wire will enable electric motors and generators to operate at much higher power densities. When compared to a copper wire based electric machine with equivalent output power, future superconducting motors and generators will enable significant size reductions for the motors with higher efficiency. One potential application for high-powered HTS generators is expected to be 10+ megawatt offshore wind turbines. Offshore superconducting wind turbines promise to capture clean energy at a lower cost than competing renewables, while delivering power directly to growing coastal cities. Offshore superconducting wind turbines are a long-term initiative for HTS technologies. Wind energy is taking shape as a critical world resource for electric power. Today, wind energy is primarily land based. The expected future trend is to exploit a largely untapped supply of offshore wind energy. However, it will take time to build enough infrastructure for offshore wind power to significantly contribute to the power grid. Superconducting wind turbines are expected to play a unique role offshore since conventional technology cannot achieve the necessary “power per tower”. The increase in power density provided by superconducting turbines significantly reduces generator weight and maximizes power per tower, turning wind power into an economically viable alternative. Size reduction translates directly to cost savings by greatly reducing the amount of magnetic steel and structural steel required. Superior 2G HTS wire power handling performance at a lower cost will enable superconducting wire to replace incumbent and competing technologies.

RF Filters

Conventional RF filters are fabricated primarily from aluminum blocks with hollow cavities, resonators, and tuning elements incorporated to make a frequency specific filter. Our filter structures resemble a circuit on a semiconductor using a circuit that is etched into HTS materials that are deposited on a wafer. Our unique and innovative circuits allow us to utilize the characteristics of the HTS materials for this application. We have also developed unique tuning methods that allow us to produce a frequency specific filter.

In July 2012 we announced we were contributing 14 patents regarding our innovative Reconfigurable Resonance™ (RcR) technology, experienced executive leadership and technical expertise as our minority investment in Resonant LLC. Resonant intends to commercialize RcR for the mobile communication products industry. The contributed patents do not relate to either our current wireless business nor to our 2G HTS wire initiative.

 

18


Table of Contents

Cryocoolers

HTS circuits need to be cooled to the critical temperature that enables the superconducting properties of the materials to be utilized. To meet this need, we developed a unique cryocooler that can efficiently and reliably cool the circuit to the critical temperature (77 degrees Kelvin). As a result, our wireless products are maintenance free and reliable enough to be deployed for many years.

Results of Operations

Quarter and six months ended June 30, 2012 compared to the quarter and six months ended July 2, 2011

Net revenues decreased by $520,000 or 47%, to $596,000 in the second quarter of 2012 from $1.1 million in the second quarter of 2011. Total net revenues decreased by $1.7 million, or 64%, to $995,000 in the first six months of 2012 from $2.7 million in the same period of 2011. Net revenues consist primarily of commercial product revenues and government contract revenues.

Net commercial product revenues decreased by $572,000, or 52%, to $529,000 in the second quarter of 2012 from $1.1 million in the second quarter of 2011. The decrease is the result of lower sales volume for our SuperLink products. For the first six months of 2012, net commercial revenue decreased to $873,000 from $2.7 million in the same period of 2011, a decrease of $1.8 million, or 68%. The decrease in the six month period was the result of lower sales of both our SuperLink and AmpLink products. We sell our SuperLink and other performance enhancement products to large North American wireless operators. As our customers continue to invest in 4G networks, spending on 3G data networks, where our products are deployed, has become a secondary priority. This market dynamic has impacted and we believe will continue to impact our commercial revenue. The average sales prices for our products were unchanged. Our three largest customers accounted for 95% of our total net commercial product revenues in the first six months of 2012 and 99% in the same period of 2011. These customers generally purchase products through non-binding commitments with minimal lead-times. We also continue to experience challenges to revenue growth in the commercial wireless market. Consequently, our commercial product revenues can fluctuate dramatically from quarter to quarter based on changes in our customers’ capital spending patterns, and revenues may continue to be impacted by such challenges.

Government contract and other revenues increased by $52,000 from $15,000 in the second quarter of 2011 to $67,000 in the second quarter of 2012. For the first six months of 2012, government contract revenues increased to $122,000 from $32,000, an increase of $90,000, or 281%. This increase is attributable to the addition of two small government contracts procured in early 2012.

Cost of commercial product revenues includes all direct costs, manufacturing overhead and provision for excess and obsolete inventories. The cost of commercial product revenues decreased to $1.1 million in the second quarter of 2012 compared to $1.3 million for the second quarter of 2011, a decrease of $187,000 or 15%. For the first six months of 2012, the cost of commercial product revenues totaled $1.9 million compared with $2.9 million for the first six months of 2011, a decrease of $1.0 million, or 34%. The lower costs resulted principally from lower production as a result of lower sales. We had an expense provision for obsolete inventories in the first half of 2012 of $182,000 compared to no expense provision in the first half of 2011.

Our cost of commercial sales includes both variable and fixed cost components. The variable component consists primarily of materials, assembly and test labor, overhead, which includes equipment and facility depreciation, transportation costs and warranty costs. The fixed component includes test equipment and facility depreciation, purchasing and procurement expenses and quality assurance costs. Given the fixed nature of such costs, the absorption of our production overhead costs into inventory decreases and the amount of production overhead variances expensed to cost of sales increases as production volumes decline since we have fewer units against which to absorb our overhead costs. Conversely, the absorption of our production overhead costs into inventory increases and the amount of production overhead variances expensed to cost of sales decreases as production volumes increase since we have more units against which to absorb our overhead costs. As a result, our gross profit margins generally decrease as revenue and production volumes decline due to lower sales volume and higher amounts of production overhead variances expensed to cost of sales; and our gross profit margins generally increase as our revenue and production volumes increase due to higher sales volume and lower amounts of production overhead variances expensed to cost of sales.

 

19


Table of Contents

The following is an analysis of our commercial product gross loss:

 

Dollars in thousands    Three Months Ended     Six Months Ended  
     June 30, 2012     July 2, 2011     June 30, 2012     July 2, 2011  

Net commercial product sales

   $ 529        100   $ 1,101        100   $ 873        100   $ 2,704        100

Cost of commercial product sales

     1,078        204     1,265        115     1,922        220     2,934        109
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross loss

   $ (549     (104 )%    $ (164     (15 )%    $ (1,049     (110 )%    $ (230     (9 )% 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

We had a gross loss of $549,000 in the second quarter of 2012 from the sale of our commercial products compared to a gross loss of $164,000 in the second quarter of 2011. We experienced a gross loss in the second quarters of 2012 and 2011 because the level of commercial sales was insufficient to cover our fixed manufacturing overhead costs. We regularly review inventory quantities on hand and provide an allowance for excess and obsolete inventory based on numerous factors including sales backlog, historical inventory usage, forecasted product demand and production requirements for the next twelve months. Gross margin in the second quarters and first six months of 2012 and 2011 was not impacted by the sale of previously written-off inventory.

Cost of government and other contract revenues totaled $43,000 in the second quarter of 2012 compared to $15,000 in the second quarter of 2011 and $95,000 in the first half of 2012 compared to $30,000 in the first half of 2011. This increase was the result of higher expenses associated with more revenue from government contracts. Because these contracts are generally priced on a “cost plus” basis, increases in revenue generally result in increases in associated costs. As a percentage of government and other contract revenues, these costs decreased to 78% in the first half of 2012 compared to 99% in the first half of 2011 because of the cost plus nature of the contracts.

Research and development expenses relate principally to development of our HTS wire products and other products related to our expertise. These expenses totaled $1.3 million and $2.5 million, respectively, in the three and six months ended June 30, 2012 compared to $1.4 million and $3.3 million in the three and six month period ended July 2, 2011. These expenses were $0.8 million higher in the prior six month period when we voluntarily terminated a patent license we had with a third party along with certain other related intangible assets. As a result, capitalized cost was charged to expense during the six months ended July 2, 2011.

Selling, general and administrative expenses totaled $1.6 million and $3.0 million, respectively, in the three and six months ended June 30, 2012 compared to $1.7 million and $3.3 million in the three and six months ended July 2, 2011. The reduction was primarily from lower sales expenses.

Interest income for the three and six months ended June 30, 2012 was $3,000 and $5,000 respectively compared to $2,000 and $4,000, respectively, in the three and six months ended July 2, 2011. The increases resulted from higher interest rates in the 2012 periods.

There was no interest expense for the three and six months ended June 30, 2012. Interest expense for the three and six months ended July 2, 2011 was $7,000 and $14,000, respectively, and was the result of our line of credit with a bank. We had not used the line of credit in a number of years and allowed it to expire in 2011.

We had a net loss of $3.4 million for the quarter ended June 30, 2012, compared to a net loss of $3.2 million in the same period of 2011. For the six months ended June 30, 2012 our loss totaled $6.4 million compared to a net loss of $6.9 million for the six months ended July 2, 2011.

The net loss available to common stockholders totaled $0.09 per common share in the second quarter of 2012, compared to a net loss of $0.10 per common share in the same period of 2011. The net loss available to common stockholders totaled $0.17 per common share in the first half of 2012 compared to $0.22 per common share in the first half of 2011.

Liquidity and Capital Resources

Cash Flow Analysis

As of June 30, 2012, we had working capital of $5.6 million, including $5.4 million in cash and cash equivalents, compared to working capital of $7.2 million at December 31, 2011, which included $6.2 million in cash and cash equivalents. We currently invest our excess cash in short-term, investment-grade, money-market instruments with maturities of three months or less.

Cash and cash equivalents decreased by $0.8 million from $6.2 million at December 31, 2011 to $5.4 million at June 30, 2012. Cash was provided by financing activities offset by uses in operations and by purchases of property and equipment.

 

20


Table of Contents

Cash used in operations totaled $5.5 million in the first six months of 2012. We used $5.4 million to fund the cash portion of our net loss. We also used cash to fund a $337,000 increase in accounts receivable and patents, offset by cash provided by a $420,000 decrease in inventory and other assets, as well as an increase in accounts payable and accrued expenses.

Net cash used in investing activities totaled $1.8 million in the first six months of 2012. Purchases of equipment for our HTS wire initiative were $1.8 million and $37,000 was provided by equipment sales. In the first six months of 2011, we used $647,000 to purchase property and equipment and there were no equipment sales.

We used $134,000 in financing activities in the first six months of 2012 compared to $303,000 in the first six months of 2011 to repurchase common shares from our employees to satisfy tax withholding obligations that arose upon the vesting of restricted stock awards.

Financing Activities

We have historically financed our operations through a combination of cash on hand, cash provided from operations, equipment lease financings, available borrowings under bank lines of credit and both private and public equity offerings.

Net cash provided by financing activities through June 30, 2012 totaled $6.6 million, net of $582,000 in expenses. The financing was from two activities: the registered direct sale of 6,711,219 shares of common stock at $1.05 per share in February 2012 and at-the-market sales to or through Citadel Securities of 97,372 shares of common stock at an average price of $1.60 per share in January and early February 2012. These financing activities were slightly offset in the first six months of 2012 by the $134,000 used to repurchase shares from our employees to satisfy tax withholding obligations mentioned above.

Contractual Obligations and Commercial Commitments

We have not had any material changes outside of the ordinary course of business in our contractual obligations as disclosed in our Annual Report on Form 10-K for 2011.

Capital Expenditures

We plan to invest approximately $2.1 million in fixed assets during the remainder of 2012. This $2.1 million and the $1.9 million already spent in the first six months of 2012 are for the purchase of equipment and facilities improvements for our HTS wire initiative. There have been no fixed asset expenditures in the six months ended June 30, 2012, and we do not plan any additional fixed asset expenditures in 2012 for our existing wireless business.

Future Liquidity

For the first six months of 2012, we incurred a net loss of $6.4 million and had negative cash flows from operations of $5.5 million. In the full 2011 year, we incurred a net loss of $13.4 million and had negative cash flows from operations of $10 million. Our independent registered public accounting firm has included in their audit reports for 2011 and 2010 an explanatory paragraph expressing doubt about our ability to continue as a going concern.

At June 30, 2012, we had $5.4 million in cash and cash equivalents. We believe our cash resources will not be sufficient to fund our business for at least the next twelve months. We believe the key factors to our liquidity will be our ability to successfully use our expertise and our technology to generate revenues in various ways, including commercial operations, government contracts, joint ventures and licenses and we plan to leverage our leadership in superconducting technologies, extensive intellectual property, and HTS manufacturing expertise to develop and produce HTS wire. Because of the uncertainty of these factors, we will need to raise funds to meet our working capital needs. If we require additional financing, we cannot assure you that additional financing will be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. If we cannot raise any needed funds, we might be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.

Net Operating Loss Carryforward

As of December 31, 2011, we had net operating loss carryforwards for federal and state income tax purposes of approximately $308.4 million and $181.5 million, respectively, which expire in the years 2012 through 2031. However, during 2011 we concluded that under the Internal Revenue Code change of control limitations, a maximum of $94.4 million and $70.2 million, respectively, would be available for reduction of taxable income and reduced both the deferred tax asset and valuation allowance accordingly. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.

 

21


Table of Contents

Critical Accounting Policies and Estimates

Our discussion and analysis of our historical financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these condensed consolidated financial statements in conformity with those principles requires us to make estimates of certain items and judgments as to certain future events including, for example, those related to bad debts, inventories, recovery of long-lived assets (including intangible assets), income taxes, warranty obligations, and contingencies. These determinations, even though inherently subjective and subject to change, affect the reported amounts of our assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. While we believe that our estimates are based on reasonable assumptions and judgments at the time they are made, some of our assumptions, estimates and judgments will inevitably prove to be incorrect. As a result, actual outcomes will likely differ from our accruals, and those differences – positive or negative – could be material. Some of our accruals are subject to adjustment, as we believe appropriate, based on revised estimates and reconciliation to the actual results when available.

In addition, we identified certain critical accounting policies which affect certain of our more significant estimates and assumptions used in preparing our consolidated financial statements in our Annual Report on Form 10-K for 2011. We have not made any material changes to these policies.

Backlog

Our commercial backlog consists of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had commercial backlog of $231,000 at June 30, 2012, compared to $13,000 at December 31, 2011.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We do not believe that there was a material change in our exposure to market risk at June 30, 2012 compared with our market risk exposure on December 31, 2011. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Market Risk” in our Annual Report on Form 10-K for 2011.

 

Item 4. Controls and Procedures.

We have established disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). As of the end of the period covered by this report we carried out an evaluation under the supervision and with the participation of our management, including the our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Securities and Exchange Act of 1934, as amended. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.

There were no changes in our internal controls over financial reporting during the quarter ended June 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We do not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

PART II

OTHER INFORMATION

 

Item 1. Legal Proceedings.

From time to time, we are party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. Excluding ordinary, routine litigation incidental to our business, we are not currently a party to any legal proceedings that we believe would reasonably be expected to have a material adverse effect on our business, financial condition or results of operation or cash flow.

 

Item 1A. Risk Factors.

A description of the risk factors associated with our business is contained in Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for 2011 filed with the Securities and Exchange Commission on March 30, 2012. We are not aware of any material changes to those risk factors.

 

22


Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table summarizes repurchases of our common stock in the quarter ended June 30, 2012:

 

Period

   Total Number of  Shares
Purchased(1)
    Average Price Paid  Per
Share
 

April 1 - April 28, 2012

     —        $ —     

April 29 - May 26, 2012

     7,233 (1)     .68   

May 27 - June 30, 2012

     —          —     
  

 

 

   

 

 

 

Total

     7,233      $ .68   
  

 

 

   

 

 

 

 

(1) Shares surrendered to us by employees to satisfy tax withholding obligations that arose upon the vesting of restricted stock awards. These repurchases were not made pursuant to publicly announced plans or programs.

 

Item 3. Defaults Upon Senior Securities.

None.

 

Item 4. Mine Safety Disclosures.

None.

 

Item 5. Other Information.

None.

 

Item 6. Exhibits.

 

Number

  

Description of Document

  10.1    Consulting Agreement, dated May 5, 2012 between Superconductor Technologies Inc. and John Lockton (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 10, 2012).
  10.2    Consulting Agreement, dated May 6, 2012 between Superconductor Technologies Inc. and Dennis Horowitz (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 10, 2012).
  31.1    Statement of CEO Pursuant to 302 of the Sarbanes-Oxley Act of 2002*
  31.2    Statement of CFO Pursuant to 302 of the Sarbanes-Oxley Act of 2002*
  32.1    Statement of CEO Pursuant to 906 of the Sarbanes-Oxley Act of 2002*
  32.2    Statement of CFO Pursuant to 906 of the Sarbanes-Oxley Act of 2002*
101.INS    XBRL Instance Document**
101.SCH    XBRL Taxonomy Extension Schema Document**
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB    XBRL Taxonomy Extension Label Linkbase Document**
101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document**

 

* Filed herewith.
** Users of this data are advised that pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on our behalf by the undersigned thereunto duly authorized.

 

      SUPERCONDUCTOR TECHNOLOGIES INC.
Dated: August 14, 2012      

/s/ William J. Buchanan

      William J. Buchanan
      Chief Financial Officer
     

/s/ Jeffrey A. Quiram

      Jeffrey A. Quiram
      President and Chief Executive Officer

 

24

XNAS:SCON Superconductor Technologies Inc Quarterly Report 10-Q Filling

Superconductor Technologies Inc XNAS:SCON Stock - Get Quarterly Report SEC Filing of Superconductor Technologies Inc XNAS:SCON stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:SCON Superconductor Technologies Inc Quarterly Report 10-Q Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:SCON Superconductor Technologies Inc Quarterly Report 10-Q Filing - 3/31/2012  |  Next: XNAS:SCOR comScore Inc Insider Activity 3 Filing - 3/5/2012